AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Amyris, Inc.

5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
510 450 0761

Sector(s)Basic Materials
IndustrySpecialty Chemicals
Full-time employees1,598

Key executives

NameTitlePayExercisedYear born
Mr. John G. MeloPres, CEO & Director967.68kN/A1966
Mr. Hermanus KieftenbeldCFO & Chief Admin. Officer644.71kN/A1966
Mr. Eduardo AlvarezChief Operating Officer687.62kN/A1964
Ms. Elizabeth E. Dreyer CPAChief Accounting Officer & Corp. ControllerN/AN/A1962
Mr. Peter DeNardoSr. Director of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Doris ChoiGen. Counsel & Sec.N/AN/A1978
Ms. Christine OforiChief People OfficerN/AN/AN/A
Mr. Jim IacoponiSr. VP of Nutrition IngredientsN/AN/AN/A
Ms. Beth Baker BannermanChief Engagement & Sustainability OfficerN/AN/AN/A
Sunil ChandranChief Science Officer and Head of R&DN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Corporate governance

Amyris, Inc.’s ISS governance QualityScore as of 1 May 2023 is 9. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.